Hamilton Lane
HLNE
$100.84
-3.26%
Hamilton Lane Incorporated is a leading private markets investment firm that provides institutional and private wealth investors with access to private equity, real estate, infrastructure, and other alternative asset classes. The firm distinguishes itself through its specialized focus on private markets, managing approximately $986 billion in assets under management and supervision, with a global footprint across North America, Europe, Asia Pacific, and the Middle East. The current investor narrative centers on the firm's strategic expansion into private wealth channels and its ability to sustain fee-related earnings growth amid a challenging fundraising environment, while the stock has experienced significant volatility over the past year, reflecting broader market concerns about private market valuations and liquidity.…
HLNE
Hamilton Lane
$100.84
Investment Opinion: Should I buy HLNE Today?
Based on the analysis, Hamilton Lane is rated a Buy. The stock offers a compelling risk/reward with a 28% upside to the average analyst target of $133.57, supported by a strong profitability profile and a 25% valuation discount to peers. The consensus recommendation of 'buy' and a mean score of 1.57 further reinforce the bullish stance.
Sign up to view all
HLNE 12-Month Price Forecast
The AI assessment is bullish on Hamilton Lane, driven by its strong profitability, attractive valuation, and positive analyst sentiment. The stock's 25% discount to peers and 28% upside to the average target provide a favorable risk/reward. However, the medium confidence reflects the uncertainty in private market conditions and the stock's high volatility. The stance would be upgraded to high confidence if the company delivers strong earnings growth and AUM expansion, while a downgrade would occur if revenue growth decelerates or margins compress.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hamilton Lane's 12-month outlook, with a consensus price target around $133.57 and implied upside of +32.5% versus the current price.
Average Target
$133.57
0 analysts
Implied Upside
+32.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$105 - $182
Analyst target range
Hamilton Lane is covered by 7 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 1.57 (where 1 is strong buy and 5 is sell). The average target price is $133.57, implying approximately 28% upside from the current price of $104.24. The target price range spans from a low of $105.00 to a high of $182.00, indicating a wide dispersion of views. The high target suggests that some analysts see significant upside potential, likely driven by continued AUM growth and margin expansion, while the low target implies limited upside, possibly reflecting concerns about market headwinds. The wide spread between the low and high targets (77 points) signals high uncertainty about the stock's future performance, which is typical for a mid-cap asset manager in a volatile market environment.
Bulls vs Bears: HLNE Investment Factors
Hamilton Lane presents a mixed picture: strong profitability, attractive valuation, and analyst optimism are countered by a significant price decline, high volatility, and dependence on cyclical private markets. Currently, the bull case has stronger evidence, given the 25% valuation discount and 28% upside to the average target, but the bear case highlights real risks that could derail the thesis. The most important tension is whether the firm can sustain its revenue growth and margin expansion in a challenging fundraising environment, as this will determine if the current discount is warranted or if further downside is ahead.
Bullish
- Strong profitability and margins: Hamilton Lane boasts a net margin of 32.83% and an operating margin of 42.81%, indicating a highly efficient and scalable business model. These margins are significantly above the industry average, reflecting the firm's ability to convert revenue into profits effectively.
- Attractive valuation discount: The trailing PE of 16.59x and forward PE of 14.13x are well below the industry average of 22x, representing a 25% discount. This suggests the stock is undervalued relative to peers, providing a margin of safety for investors.
- Analyst consensus and upside: With a consensus rating of 'buy' and an average target price of $133.57, the stock implies approximately 28% upside from the current price of $104.24. The high target of $182.00 suggests even greater potential if the company executes well.
- Robust revenue growth: The latest quarterly revenue is estimated at $1.16 billion (annualized), reflecting strong growth driven by the firm's private markets platform. This growth is expected to continue, with forward EPS estimates of $8.33, implying a 17% earnings growth rate.
Bearish
- Significant price decline: The stock has fallen 34.21% over the past year, underperforming the S&P 500's +20.37% gain by a wide margin. This downtrend reflects investor concerns about private market valuations and liquidity, which could persist.
- High volatility and beta: With a beta of 1.173, the stock is moderately more volatile than the market, amplifying downside moves. The 52-week range of $71.88 to $159.47 shows substantial price swings, indicating elevated risk.
- PEG ratio suggests fair value: The PEG ratio of 1.67 indicates that the stock is not deeply undervalued when accounting for growth. This suggests that the market is pricing in reasonable expectations, limiting potential for multiple expansion.
- Dependence on private markets: The firm's business is heavily tied to private markets, which are cyclical and sensitive to interest rates and liquidity conditions. A prolonged downturn in private market activity could pressure AUM growth and fee-related earnings.
HLNE Technical Analysis
Hamilton Lane's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -34.21%, significantly underperforming the S&P 500's +20.37% gain. The current price of $104.24 sits at approximately 35% of its 52-week range (between the low of $71.88 and high of $159.47), indicating that the stock is closer to its lows than its highs, which could suggest either a value opportunity or a falling knife depending on the fundamental outlook. The stock's beta of 1.173 indicates it is moderately more volatile than the market, amplifying both downside and upside moves.
Beta
1.17
1.17x market volatility
Max Drawdown
-54.1%
Largest decline past year
52-Week Range
$72-$159
Price range past year
Annual Return
-35.1%
Cumulative gain past year
| Period | HLNE Return | S&P 500 |
|---|---|---|
| 1m | +17.5% | +4.0% |
| 3m | +19.9% | +5.3% |
| 6m | -18.1% | +12.6% |
| 1y | -35.1% | +20.1% |
| ytd | -26.2% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HLNE Fundamental Analysis
Hamilton Lane's revenue trajectory has been robust, with the latest quarterly revenue estimated at approximately $1.16 billion (annualized), reflecting a strong growth profile driven by its private markets platform. The firm's net margin stands at 32.83%, and its gross margin is 69.88%, indicating high profitability and a scalable business model. The operating margin of 42.81% further underscores operational efficiency, though the lack of quarterly revenue breakdowns limits visibility into segment-specific drivers.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HLNE Overvalued?
Given that Hamilton Lane is profitable, the PE ratio is the primary valuation metric. The trailing PE is 16.59x, while the forward PE is 14.13x, implying that the market expects earnings growth of approximately 17% over the next year. The PEG ratio of 1.67 suggests that the stock is reasonably valued relative to its growth rate, though it is not a deep value. Compared to the industry average PE of 22x (based on available data), Hamilton Lane trades at a 25% discount, which may reflect concerns about the cyclicality of private markets or the firm's relatively smaller scale versus peers.
PE
16.6x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks: Hamilton Lane's financial health is generally sound, with a debt-to-equity ratio of 0.39 and a current ratio of 1.62, indicating manageable leverage and adequate liquidity. However, the firm's revenue is highly dependent on private markets, which are cyclical and sensitive to interest rates and liquidity conditions. A prolonged downturn in private market activity could reduce AUM growth and fee-related earnings, impacting the firm's profitability. Additionally, the payout ratio of 56.92% suggests a significant portion of earnings is returned to shareholders, which could limit reinvestment in growth initiatives if earnings decline.
FAQ
The key risks include: (1) financial risk from dependence on cyclical private markets, which could reduce AUM growth and earnings; (2) market risk from high volatility (beta 1.173) and potential valuation compression; (3) competitive risk from larger asset managers and passive investing; and (4) regulatory risk from increased scrutiny of private market practices. The most severe risk is a prolonged downturn in private markets, which could push the stock down to its 52-week low of $71.88, a 31% downside. Investors should monitor fundraising trends and interest rates.
The 12-month forecast for HLNE is moderately bullish. The base case, with a 50% probability, sees the stock reaching the average analyst target of $133.57, a 28% upside. The bull case, with a 30% probability, could push it to $182.00, while the bear case, with a 20% probability, could see it fall to $71.88. The most likely scenario is the base case, assuming moderate growth in AUM and fee-related earnings. Investors should watch for earnings results and market conditions to gauge which scenario unfolds.
Hamilton Lane appears undervalued relative to its peers and its own growth prospects. The trailing PE of 16.59x and forward PE of 14.13x are below the industry average of 22x, representing a 25% discount. The PEG ratio of 1.67 suggests the stock is fairly valued relative to its growth rate, but the strong margins and ROE justify a premium. The market is pricing in moderate growth, but if the company delivers on its estimates, the stock could re-rate higher. Overall, the valuation is attractive for a high-quality asset manager.
Hamilton Lane is a good buy for investors seeking exposure to private markets with a strong profitability profile. The stock trades at a 25% discount to the industry average PE, offering a margin of safety, and analysts see a 28% upside to the average target of $133.57. However, the stock is volatile with a beta of 1.173, and the 34% decline over the past year highlights the risks. It is a good buy for those with a long-term horizon and tolerance for volatility, but not for short-term traders or risk-averse investors.
HLNE is more suitable for long-term investment due to its growth profile and the cyclical nature of private markets. The stock has a beta of 1.173, indicating high volatility, which makes it risky for short-term trading. The company's strong fundamentals, including a 32.83% net margin and 27.23% ROE, support a long-term holding period of at least 3-5 years to ride out market cycles. Short-term traders may find opportunities in the stock's volatility, but the high risk and uncertainty make it less ideal for short-term strategies.